CompanyNBPNasdaqRockville, MD

NovaBridge Biosciences

NovaBridge Biosciences develops therapeutic programs in oncology and ophthalmology.

SEC EDGAR ClinicalTrials.gov novabridge.com

6-KSep 8Latest SEC filing, period to Sep 8

Sep 8Latest story

September 2026

NovaBridge names Martin Dewhurst as independent director

Sep 8PeopleNovaBridge Biosciences

August 2026

NovaBridge reports H1 2026 results, targets year-end Phase 3 start for givastomig

Aug 20PeopleNovaBridge Biosciences

July 2026

NovaBridge Biosciences adopts 2026 Omnibus Share Incentive Plan

Jul 17PeopleNovaBridge Biosciences

June 2026

NovaBridge Biosciences names Srishti Gupta as CEO, succeeding Sean Fu

Jun 29PeopleNovaBridge Biosciences